Skip to main content
Premium Trial:

Request an Annual Quote

GeneMedicine Appoints Louis Smith to Direct Intratumoral Program

Premium

THE WOODLANDS, Texas--GeneMedicine, developer of nonviral gene therapy products for the treatment or prevention of disease, announced the appointment of Louis Smith as director of its intratumoral program. Smith, who has served as a consultant to GeneMedicine since the company's founding in 1993, will continue to lead a scientific team creating novel gene delivery and gene expression technologies to increase the extent, levels, and duration of expression of therapeutic genes in tumors after direct injection of gene medicines. Since last year, Smith has been on sabbatical from his position as professor of medicine, biochemistry, cell biology, and molecular biophysics at Baylor College of Medicine. Since 1990, his research efforts have been primarily directed at the development of synthetic systems for DNA plasmid delivery in vivo using lipophilic peptides and cationic lipids.

Gene medicines deliver genetic instructions to targeted cells in the body to produce therapeutic proteins or desired immune responses. The company recently completed patient enrollment of its Phase I human clinical trials for its IL-2 gene medicine for the treatment of head and neck cancer, and is undertaking preclinical work for two additional cytokine-based gene medicines utilizing the genes for interferon-(alpha) and IL-12.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.